Posterior Segment Infection and Inflammation

Noninfectious Uveitis: Personalizing Treatment to Improve Outcomes

Noninfectious Uveitis: Personalizing Treatment to Improve Outcomes

Noninfectious uveitis continues to be a leading cause of preventable blind…

Expiration Date: 4/29/2021

Max Credits: 0

Rapid Response from Chicago: Advances in the Long-term Management of Non-infectious Uveitis

Rapid Response from Chicago: Advances in the Long-term Management of Non-infectious Uveitis

Non-infectious uveitis is a leading cause of preventable blindness worldwi…

Expiration Date: 11/7/2019

Max Credits: 0

Non-infectious Uveitis: Moving Beyond the Standard of Care with an Eye on the Evidence

Non-infectious Uveitis: Moving Beyond the Standard of Care with an Eye on the Evidence

Uveitis is one of the leading causes of preventable blindness worldwide wi…

Expiration Date: 12/16/2019

Max Credits: 0

New Treatment Options in Uveitis

New Treatment Options in Uveitis

Noninfectious uveitis continues to be a leading cause of preventable blind…

Expiration Date: 5/30/2021

Max Credits: 0

Impact of Treatment Protocol on Long-Term Outcomes – Frequency of Injections, Fixed Interval Dosing, Treat and Extend, PRN

Impact of Treatment Protocol on Long-Term Outcomes – Frequency of Injections, Fixed Interval Dosing, Treat and Extend, PRN

Anti-vascular endothelial growth factor (anti-VEGF) therapy has become sta…

Expiration Date: 6/29/2021

Max Credits: 0

Assessing Retinal Fluid – Does Early Anatomic Dryness Make a Difference in Outcomes?

Assessing Retinal Fluid – Does Early Anatomic Dryness Make a Difference in Outcomes?

Anti-vascular endothelial growth factor (anti-VEGF) therapy has become sta…

Expiration Date: 6/29/2021

Max Credits: 0

Extending the Anti-VEGF Treatment Interval and Its Effect on Visual Outcomes

Extending the Anti-VEGF Treatment Interval and Its Effect on Visual Outcomes

Anti-vascular endothelial growth factor (anti-VEGF) therapy has become sta…

Expiration Date: 6/29/2021

Max Credits: 0

Treatment of Proliferative Versus Non-Proliferative DR

Treatment of Proliferative Versus Non-Proliferative DR

Anti-vascular endothelial growth factor (anti-VEGF) therapy has become sta…

Expiration Date: 6/29/2021

Max Credits: 0

Optimization of Treatment Dosing to Achieve Regression of Diabetic Retinopathy

Optimization of Treatment Dosing to Achieve Regression of Diabetic Retinopathy

Anti-vascular endothelial growth factor (anti-VEGF) therapy has become sta…

Expiration Date: 6/29/2021

Max Credits: 0

New Treatment Options in Uveitis

New Treatment Options in Uveitis

Noninfectious uveitis continues to be a leading cause of preventable blind…

Expiration Date: 5/30/2021

Max Credits: 0

1
2